The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Onbrez Breezhaler



Novartis Europharm LimitedEU/1/09/593/6-10

Main Information

Trade NameOnbrez Breezhaler
Active SubstancesIndacaterol maleate
Dosage FormInhalation powder, hard capsule
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/09/593/6-10

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC18 indacaterol

Status

License statusAuthorised
Licence Issued30/11/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back